EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PNKD Mediates Lactate‐Driven Tumor Progression in Clear Cell Renal Cell Carcinoma

Xinfang Zhang, Wei Guo, Minghui Yu, Yijia Wang, Bing Cui, Yaohua Zhang, Jun Yan, Kaichen Wang

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/8430177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 27.03.2026. Verfasst von Xinfang Zhang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Outstanding Youth Science Fund Project of National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is a metabolically reprogrammed malignancy in which lactate accumulation is increasingly recognized as a functional driver of tumor progression rather than a passive by‐product of glycolysis. In this study, we used multiomics data and experiments to reveal lactate‐related gene expression differences and identified PNKD as a new metabolic regulator that links lactate production to cancer‐promoting signaling. Lactate‐related clustering revealed two molecular subtypes with distinct prognostic patterns, immune phenotypes, and tumor mutation burden. A five‐gene prognostic signature was established and validated, enabling robust risk stratification across cohorts. Among the signature genes, PNKD exhibited the strongest tumor‐associated expression trend and was functionally confirmed to enhance lactate production, accelerate cell‐cycle progression, and promote tumor growth. Mechanistically, PNKD activated the PI3K–AKT–mTOR axis, and pharmacological PI3K inhibition reversed PNKD‐induced metabolic and proliferative phenotypes in vitro and in vivo. Moreover, spatial colocalization of PNKD and phosphorylated ribosomal protein S6 (p‐S6) in xenografts indicated that PNKD‐high regions represent metabolically active proliferative niches. These findings establish PNKD as a lactate‐driven oncogenic effector and highlight the therapeutic potential of targeting lactate metabolism–signaling crosstalk in ccRCC.

Förderung

  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Zitieren

APA

Zhang, X., Guo, W., Yu, M., Wang, Y., Cui, B., Zhang, Y., Yan, J., & Wang, K. (2026). PNKD Mediates Lactate‐Driven Tumor Progression in Clear Cell Renal Cell Carcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/8430177

Vancouver

Zhang X, Guo W, Yu M, Wang Y, Cui B, Zhang Y, et al. PNKD Mediates Lactate‐Driven Tumor Progression in Clear Cell Renal Cell Carcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/8430177

BibTeX
@article{Zhang2026,
  author = {Zhang, Xinfang and Guo, Wei and Yu, Minghui and Wang, Yijia and Cui, Bing and Zhang, Yaohua and Yan, Jun and Wang, Kaichen},
  title = {PNKD Mediates Lactate‐Driven Tumor Progression in Clear Cell Renal Cell Carcinoma},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/8430177}
}
Kostenlos starten →